Cardiovascular diseases (CVD) have been identified as a major health concern in India, contributing to 28.1% of total deaths, according to a study published in The Lancet Global Health. A concerning trend has been highlighted with the growing number of young adults affected by heart disease, with 1 in 5 heart attack patients globally now reported to be under the age of 40. The Cardiologist Society of India (CSI) has recommended lipid profile testing to begin at the age of 18, using non-fasting measurements, reflecting the urgent need for early detection. The rise in heart disease cases is primarily attributed to unhealthy lifestyles, high stress, poor dietary habits, and an increased prevalence of diabetes and hypertension.
In response to the escalating cardiovascular crisis, Metropolis Healthcare has launched the ‘Healthy Heart Meter’ campaign, coinciding with World Heart Day. This initiative has been designed to promote preventive heart care and raise awareness about cardiovascular health. The campaign includes a simple 10-question survey, which helps individuals assess their risk factors based on their lifestyle, medical history, and other key health indicators. Participants are categorized into Low, Medium, or High risk based on their answers. Those in the Medium-risk category are advised to undergo a non-fasting lipid profile test, while those identified as High risk are recommended to take the comprehensive ‘TruHealth Heart Meter Pack,’ which includes multiple diagnostic tests and an optional ECG. Metropolis’ TruHealth Wellness Packages have been developed by senior subject matter experts, with the support of clinicians, to provide a holistic assessment of an individual’s internal health.
Surendran Chemmenkotil, Chief Executive Officer of Metropolis Healthcare, has stated that the company remains committed to managing chronic health conditions effectively while promoting overall wellness. He emphasized that increased awareness and education on heart health can facilitate early detection, potentially preventing severe outcomes. Dr. Kirti Chadha, Chief Scientific and Innovation Officer, stressed the importance of early lipid testing, as dyslipidemia is a major contributor to heart attacks. The recent adoption of non-fasting lipid testing, as recommended by the CSI, was highlighted as a step towards enhancing early detection.
The survey can be completed online, through QR codes at Metropolis centers, or during home visits. Participants will receive their heart risk category and a promotional code for discounted tests. The campaign will run until October 9, 2024, providing ample time for individuals to take control of their heart health.
(Input from various sources)
(Rehash/Ankur Deka/MSM)